Your NEJM Group Today: Earning Trust in the COVID-19 Era / Delayed Denosumab & Fracture Risk / Primary Care & Oncology Opportunities

By the Editors

Here are today's selections from across NEJM Group:

NEJM Catalyst Innovations in Care Delivery: Conversation: The President of Jefferson Health discusses how his organization has been handling COVID-19 in Philadelphia. In particular, he emphasizes the importance of establishing trust, both among staff and in the community. Listen in at the link below.

NEJM Journal Watch Women's Health: When patients were more than 16 weeks late for a repeat injection of denosumab, they were at higher risk for vertebral fracture, according to a model of a U.K. randomized trial.

NEJM CareerCenter:

• Primary care: VA Northeast Ohio Healthcare System, a major teaching affiliate of Case Western Reserve University, is seeking a clinician to serve as the full-time Associate Chief of Staff - Primary Care.

• Oncology: The Division of Cancer Medicine at Banner MD Anderson Cancer Center in Arizona is recruiting for a medical oncologist with interest and expertise in genitourinary malignancies.